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Atherosclerotic vascular disease of the lower extremities
affects 18% of men and women 55 years and older in gen-
eral medical practices.1 African Americans have a higher
prevalence of lower-extremity vascular disease than non-
Hispanic whites.2,3 The incidence of abdominal aortic
aneurysms in patients with lower extremity atherosclerotic
vascular disease is five times higher than in the general pop-
ulation.4 Treatment for both lower extremity atherosclerotic
disease and abdominal aortic aneurysms includes surgical
intervention, optimally under nonemergent conditions.
The evaluation of surgical outcomes is increasingly
important. Studies have assessed risk factors for postoper-
ative outcomes after several surgical operations.5-13 Fewer
studies, however, have developed risk models specific for
short-term mortality after elective abdominal aortic
aneurysm repair, lower extremity bypass revascularization,
and lower extremity amputation. In addition, prior litera-
ture has demonstrated that certain minority populations,
such as African Americans, are at increased risk for vascu-
lar operations, particularly lower extremity bypass grafting
surgery and lower extremity amputation.14 Few studies
have assessed the association of race with death after an
From the Houston Center for Quality of Care and Utilization Studies,
Houston VA Medical Center, and Section of Health Services Research,
Baylor College of Medicinea; the Center for Health Systems Design and
Evaluation, Institute for Health Policy, Massachusetts General
Hospital/Partners Health Care System, Harvard Medical Schoolb; the
Hines VA Cooperative Studies Program Coordinating Centerc; and
Brockton/West Roxbury VA Medical Center, Harvard Medical School,
and Brigham and Women’s Hospital.d
Competition of interest: nil.
The National Veterans Affairs Surgical Quality Improvement Program was
funded by the Office of Quality Management, Patient Care Services, and
the Health Services Research and Development Service of the
Department of Veterans Affairs. Dr Gordon is supported by a Career
Development Award from the Department of Veterans Affairs. Dr Daley
was supported by a Career Development Award from Health Services
Research and Development at the time this research was conducted.
This material is based upon work supported by the Office of Research
and Development, Health Services Research and Development Service,
Department of Veterans Affairs.
The views expressed in this article are those of the authors and do not nec-
essarily represent the views of the Department of Veterans Affairs.
Reprint requests: Tracie Collins, MD, MPH, Dept of Veterans Affairs, 2002
Holcombe Blvd (152), Houston, TX 77030 (e-mail: tcollins@bcm.
tmc.edu).
24/1/117329
doi:10.1067/mva.2001.117329
Preoperative risk factors for 30-day mortality after
elective surgery for vascular disease in Department
of Veterans Affairs hospitals: Is race important?
Tracie C. Collins, MD, MPH,a Michael Johnson, PhD,a Jennifer Daley, MD,b William G. Henderson,
PhD,c Shukri F. Khuri, MD,d and Howard S. Gordon, MD,a Houston, Tex; Boston and West Roxbury, Mass;
and Hines, Ill 
Purpose: Racial variation in health care outcomes is an important topic. Risk-adjustment models have not been devel-
oped for elective abdominal aortic aneurysm repair (AAA), lower extremity bypass revascularization (LEB), or lower
extremity amputation (AMP). Earlier studies examining racial variation in mortality and morbidity from AAA, LEB,
or AMP were limited to administrative data. This study determined risk factors for mortality after surgery for vascu-
lar disease and determined whether race is an important risk factor.
Methods: Data in this prospective observational study were obtained from the Department of Veterans Affairs (VA)
National Surgical Quality Improvement Program. Detailed demographic and clinical data were collected prospectively
from patients’ medical records by trained nurse reviewers. Eligible patients were those 18 years and older who under-
went elective AAA, LEB, or AMP at one of 44 VA medical centers performing both vascular and cardiac surgery (phase
I; October 1991 to December 1993) and at one of these 44 or 79 additional VA medical centers performing vascular
but not cardiac surgery (phase II; January 1994 to August 1995). The independent association of several preoperative
factors with the 30-day postoperative mortality rate was examined with stepwise logistic regression analysis for AAA,
LEB, and AMP. Models were developed in the combined 44 VA medical centers and validated in the 79 VA medical
centers. The independent association of race with the 30-day postoperative mortality rate was examined after control-
ling for important preoperative risk factors for each operation.
Results: More than 10,000 surgical operations were examined, and 5, 3, and 10 independent preoperative predictors of
30-day mortality rate were identified for AAA, LEB, and AMP, respectively. The observed mortality rate for patients
undergoing AAA was higher (7.2% vs 3.2%; P = .02) in African American patients than in white patients in the 44 VA
medical centers, although the differences were not significant in LEB and AMP or at the additional 79 hospitals. After
important preoperative risk factors were controlled, there was no difference in 30-day mortality rates between African
American patients and white patients.
Conclusion: We identified several important preoperative risk factors for 30-day mortality rate in three vascular opera-
tions. From the results of this study, race was determined not to be an independent predictor of mortality. (J Vasc Surg
2001;34:634-40.)
elective operation for aneurysmal disease, occlusive dis-
ease, or both of the abdominal aorta and arteries of the
lower extremities.15 We sought to determine whether race
was an independent predictor of death after elective
surgery for abdominal aortic aneurysm repair, lower
extremity bypass grafting revascularization, and lower
extremity amputation.
Therefore, we conducted this study by using detailed
clinical information from the National Department of
Veterans Affairs (VA) Surgical Quality Improvement
Program (NSQIP), including findings of the medical his-
tory and results of physical and laboratory examinations.
We determined important risk factors for 30-day postop-
erative mortality for three operations performed for vascu-
lar disease. We used these risk factors to assess the
relationship of race with mortality resulting from surgery
for vascular disease.
METHODS
Data source. Data were obtained from phase I and
phase II of the VA NSQIP, a prospective, multicenter,
observational study of risk-adjusted surgical outcomes.
Phase I of the NSQIP included 44 academically affiliated
VA medical centers (VAMCs) in which cardiac and non-
cardiac operations were performed between October 1,
1991, and December 31, 1993. Phase II included 123
VAMCs (44 VAMCs from phase I and 79 additional
VAMCs) in which major surgery was performed between
January 1, 1994, and August 31, 1995. Because phase II
data include information from the original 44 VAMCs,
data from phase I and phase II for the 44 VAMCs were
combined (44 VAMCs). Data from the smaller 79 VAMCs
were analyzed separately. Patients were eligible for inclu-
sion in the NSQIP data when their operation was per-
formed with the patients under general, spinal, or epidural
anesthesia. In phase I, patients were excluded when they
were entered into the study for another index surgery
within the previous 30 days or had an operation with
known low morbidity and mortality (eg, certain ophthal-
mologic procedures). A full description of the methods of
the NSQIP has been previously described.5-8
Cases. For this study, patients were eligible if they
were 18 years or older and underwent major elective
surgery for atherosclerotic vascular disease involving the
abdominal aorta, the lower extremity vessels, or both.
Three operations were examined: lower extremity bypass
revascularization (LEB), lower extremity amputation
(AMP), and abdominal aortic aneurysm repair (AAA).
Current Procedural Terminology codes for each operation
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are listed in Table I. To minimize the effect of patient
delays in presentation, we excluded emergency operations
as defined according to the NSQIP data collection proto-
col (operations that must be performed as soon as possi-
ble and no longer than 12 hours after admission or after
the onset of symptoms). Among the three types of surg-
eries, 1339 emergency operations from the 44 VAMCs
were excluded. In these 44 VAMCs, African American
patients were more likely to undergo an emergency oper-
ation (10.1% vs 5.9%; P = .05) for AAA and for AMP
(21.4% vs 14.9%; P = .001) than white patients; for LEB,
the difference between African American and white
patients was not significant (7.1% vs 5.8%; P = .11). A total
of 284 emergency operations from the 79 VAMCs were
excluded. Among the 79 VAMCs, there was no difference
in the rate of emergency operation for AAA and LEB for
African American patients and that for white patients;
however, African American patients were more likely to
undergo emergency AMP (15.4% vs 11.1%; for AAA and
LEB P = .03). Patients whose race or ethnicity was
recorded as other than white or African American for all
hospitals from both the 44 VAMCs and 79 VAMCs were
excluded: Hispanic white (N = 548), Hispanic black (N =
17), American Indian (N = 74), Asian or Pacific islander
(N = 17), and unknown race (N = 586). Hispanic white
and Hispanic black patients were not included because the
risk factors for vascular disease and its severity are not as
well defined in these populations. Because the focus of this
paper was the mortality rate after three vascular opera-
tions, the analysis was limited to patients known to be at
high risk for peripheral vascular disease or abdominal aor-
tic aneurysms.16,17
Patients/case characteristics/outcomes. The NSQIP
nurse reviewers collected detailed demographic and clinical
data, including age, diagnosis, vital status, information from
the preoperative history and physical examination, and
results of preoperative laboratory examinations, from
patients’ medical records.
Age was defined as a continuous variable for AAA,
LEB, and AMP because this is the form that generated the
highest receiver operating characteristics curve for each
model. Race was defined within this study as African
American or white, not of Hispanic origin, as identified by
physician, physician assistant, clinical nurse specialist, or
within the medical record. Thirty-day mortality was
defined as all-cause mortality within 30 days of the index
operation. Additional data included a history of diabetes
mellitus requiring medication; hypertension requiring
medication; myocardial infarction within the previous 6
Table I. Current procedural terminology-4 coding (CPT-4) for each operation
Operations Codes
AAA 35081, 35091, 35102
LEB 35551, 35556, 35558, 35563, 35565, 35566, 35571, 35583, 35585, 35587, 35641, 35646, 35651, 35656, 35661, 
35663, 35665, 35666, 35671, 35654
AMP 27590, 27591, 27592, 27594, 27598, 27880, 27881, 27882, 27884, 27888, 27889, 28800, 28805, 28810, 28820, 
28825
months; history of congestive heart failure within 1 month
of surgery; history of moderate or severe chronic obstruc-
tive pulmonary disease (defined by means of functional
disability, an FEV1 of < 75% of predicted, chronic bron-
chodilator therapy, or earlier hospitalization); history of
transient ischemic attack; history of embolic, thrombotic,
or hemorrhagic stroke with or without residual motor,
sensory, or cognitive deficit; and history of claudication.
Habits included smoking and ethanol use of more than
two drinks per day in the 2 weeks before admission.
Findings from the physical examination included impaired
sensorium (acute confusion or delirium) and weight loss
of more than 10% body weight in the previous 6 months.
Additional data were available as a means of classifying
functional status into three levels (independent, partially
dependent, or totally dependent) according to the
patient’s ability to carry out activities of daily living. The
categorical variable functional status was coded to allow
comparison of patients who were independent with
patients who were partially or fully dependent combined
into one category. In addition, data were available from
the anesthesiologist’s five-point assessment of the risk of
perioperative death (American Society of Anesthesiology
Physical Status Class [ASA-class]). ASA-class was coded to
allow comparison of high-risk patients (ASA-class 4 or 5)
with low-risk patients (ASA-class 1, 2, or 3). All data were
more than 97% complete, with the exception of preopera-
tive laboratory variables, which were dependent on
whether the specific laboratory tests had been ordered. We
imputed values for the missing laboratory data by using
the same regression procedure as the NSQIP study team.6
Statistical analysis. The bivariate relationship between
each preoperative factor and the 30-day mortality was
determined with a t test for continuous variables and a 
χ2 test for categorical variables. The criterion for statistical
significance was a P value of .05 or less.
Multiple logistic regression was performed as a means
of determining the independent preoperative predictors of
30-day mortality. Variables were selected for entry into a
stepwise regression with a univariate P value less than .20
and were eliminated for a P value more than .10 after
adjusting for other covariates. Several variables (ie, rest
pain in the lower extremities, age, and history of chronic
obstructive pulmonary disease) were retained because of
clinical relevance. Separate logistic regression models were
produced for each of the three vascular operations (AAA,
LEB, and AMP).
Models were developed with data from the 44 VAMCs.
The reliability of the models was assessed with the method
of cross-validation, with the 79 VAMCs as the validation
sample. Model coefficients derived in the model from the 44
VAMCs were applied to the patients in the validation sam-
ple to obtain predicted probabilities of mortality. Calibration
was assessed by calculating the Hosmer-Lemeshow good-
ness of fit statistic, and discrimination was assessed by calcu-
lating the c-index, or area under the receiver operating
characteristics curve.18 Discrimination measures the ability
of the model to correctly predict death and ranges from 0.5
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(no discrimination) to 1.0 (perfect discrimination). The
hypothesis that there is no difference between the c-indices
for the models applied to the 44-VAMC cohort and the 79-
VAMC cohort was tested according to the method of
Hanley and McNeil.19 The models are considered validated
when the predicted probabilities are calibrated as measured 
by means of the Hosmer-Lemeshow Statistic (P > .05) and
have similar discrimination when the difference between the
two c-indices is not statistically significantly different from
zero (P > .05).
We examined the association of race and mortality by
using the χ2 test. In addition, we used multiple logistic
regression to examine the independent relationship of race
and mortality, after adjusting for the preoperative risk fac-
tors identified in the mortality models, as developed and
validated in the aforementioned manner. All analyses were
performed with SAS software version 6.12 for Unix (SAS
Institute, Inc, Cary, NC).
RESULTS
Postoperative mortality rate/patient characteris-
tics. In the 44 VAMCs, 10,355 elective operations for
vascular disease were eligible for study, and 3301 opera-
tions were eligible from the 79 VAMCs. In the 44
VAMCs, the 30-day postoperative mortality was 4.1%,
2.6%, and 8.8% for AAA, LEB, and AMP, respectively.
After the exclusion of emergency operations, the 30-day
postoperative mortality in the 44 VAMCs was 3.4%, 2.2%,
and 7.7% for AAA, LEB, and AMP, respectively (Table II).
In the 79 VAMCs, the 30-day postoperative mortality was
6.0%, 2.4%, and 8.4% for AAA, LEB, and AMP, respec-
tively. After excluding emergency operations, we found
these 30-day postoperative mortalities in the 79 VAMCs:
5.4% for AAA, 2.3% for LEB, and 7.0% for AMP. The
mean age of patients was greater for patients who died
than for patients who lived. The difference in mean age
was statistically significant for LEB and AMP, but not for
AAA.
Several preoperative patient characteristics from the
medical history and the physical and laboratory examina-
tions were associated with 30-day postoperative mortality.
The comorbidity ASA-class 4 or 5 was present at a higher
rate in patients who died within 30 days than in patients
who lived after all three operations (P = .002 for AAA; P
= .001 for LEB and AMP). Among patients undergoing
AAA and AMP, those who died within 30 days after oper-
ation were more likely to have documented hypertension
(78.2% vs 59.9%; P = .001 and 64.4% vs 52.9%, P = .001,
respectively) than those who survived. In addition, for
AAA, patients who died within 30 days after operation
were more likely to have a history of a transient ischemic
attack (TIA; 12.8% vs 5.1%; P = .003) than patients who
survived (Table II).
Patients who died within 30 days of AMP were more
likely to complain preoperatively of rest pain (71% vs 58%;
P = .001) than those who survived. In addition, patients
who died after LEB or AMP were more likely to have an
impaired sensorium on preoperative physical examination
(5.9% vs 2.2%, P = .01 for LEB; 30.4% vs 14.0%, P = .001
for AMP) than patients who survived. For all three opera-
tions, patients who died within 30 days of surgery were
more likely to have an elevated serum creatinine level
higher than 1.2 mg/dL (P = .001) than those who sur-
vived. The mean albumin level was significantly lower in
patients who died after AAA or AMP. In all three opera-
tions, fewer patients who died within 30 days were
assigned to ASA-class 3 than patients who survived (64.1%
vs 74.3%, P = .05 for AAA; 69.3% vs 78.1%, P = .04 for
LEB; 49.6% vs 68.0%, P = .001 for AMP; Table II).
Independent predictors of 30-day mortality rate.
We used stepwise multiple logistic regression to identify the
independent predictors of postoperative mortality in the
three vascular operations. Regression models were devel-
oped and validated for each operation. All models were val-
idated as the predicted probabilities calibrated (P > .05)
according to the Hosmer-Lemeshow Statistic. Model dis-
crimination was highest for AMP (c-index = .77) and was
lower for AAA (c-index = .69) and LEB (c-index = .69).
For AAA, the independent predictors of 30-day post-
operative mortality included age, hypertension, a history
of TIA, a low serum albumin level, a creatinine level
higher than 1.2 mg/dL, and ASA-class 4 or 5 (Table III).
AAA patients with a history of TIA were at more than two
times the risk of death at 30 days (odds ratio [OR], 2.40;
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95% CI, 1.18-4.86) than patients without TIA.
Additionally, patients with a higher albumin level were less
likely to die (OR, 0.60; 95% CI, 0.37-0.96) than patients
with an albumin level 1 g/dL lower.
The independent preoperative predictors associated
with 30-day mortality for LEB were age, dialysis, and
ASA-class 4 or 5. The preoperative factors associated with
the highest risk of death for patients undergoing LEB
were preoperative dialysis and ASA class 4 or 5 (OR, 6.21;
95% CI, 3.1, 13.0; OR, 2.06; 95% CI 1.3, 3.3, respectively;
Table III).
For AMP, the independent preoperative predictors of
mortality included age, history of chronic obstructive pul-
monary disease, absent lower extremity pulses, and
impaired sensorium (Table III). ORs for these predictors
were 1.03 (95% CI, 1.02, 1.05), 1.53 (95% CI, 1.14,
2.06), 1.39 (95% CI, 1.05, 1.83), and 1.68 (95% CI,
1.23, 2.30), respectively. In addition, patients with higher
serum albumin levels had a lower risk of death (OR, 0.59;
95% CI, 0.47, 0.74). Those risk factors associated with at
least twice the risk for 30-day mortality rate after lower
extremity amputation were ventilator dependence (OR,
3.17; 95% CI, 1.40, 7.16), a do-not-resuscitate order
(OR, 2.24; 95% CI, 1.56, 3.23), dialysis (OR, 2.50; 95%
CI, 1.62, 3.86), and a hematocrit level of 45% or more
(OR, 2.09; 95% CI, 1.06, 4.09).
Table II. Patient characteristics by 30-day postoperative mortality for three vascular operations in 44 Department of
Veterans Affairs Medical Centers
AAA LEB AMP
Dead Alive Dead Alive Dead Alive
Patient characteristic (N = 78) (N = 2190) P value (N = 101) (N = 4468) P value (N = 270) (N = 3248) P value
Mean age, y (SD) 69.20 (6.61) 68.0 (6.80) .12 68.10 (8.22) 64.40 (8.92) < .001 70.30 (9.89) 66.20 (10.82) < .001
Mean albumin level (SD) 3.57 (0.47) 3.69 (0.50) .04 3.53 (0.51) 3.59 (0.51) .19 2.90 (0.62) 3.18 (0.56) < .001
Proportion of preoperative 
variables (%)
Race (% white) 88.5 94.7 .02 86.1 81.4 .23 71.1 70.4 .79
Sex (% men) 100 99.6 .57 98.0 99.2 .21 98.5 98.9 .54
History of COPD 35.9 25.6 .04 22.8 19.0 .34 30.7 18.9 .001
History of TIA 12.8 5.1 .003 8.9 5.5 .14 4.4 4.4 .97
Rest pain* 7.7 6.0 .53 66.3 57.3 .07 71.1 58.3 .001
Diabetes mellitus 12.8 7.4 .08 33.7 31.7 .08 54.8 46.9 .01
Hypertension 78.2 59.9 .001 66.3 57.5 .07 64.4 52.9 .001
Dialysis 0 0.6 .48 9.9 1.6 .001 15.2 5.2 .001
Impaired sensorium 3.9 1.6 .13 5.9 2.2 .01 30.4 14.0 .001
Absent pulses† 14.1 15.4 .76 63.4 66.2 .56 67.8 54.7 .001
Functional status‡ 9.0 5.6 .21 26.7 14.8 .001 74.8 53.6 .001
Do-not-resuscitate order 3.9 0.6 .001 1.0 0.6 .60 20.7 5.8 .001
Ventilator dependent 0 0.1 .79 1.0 0.1 .002 4.4 0.6 .001
Creatinine level 57.7 34.5 .001 49.5 33.6 .001 52.6 36.0 .001
>1.2 mg/dL
Hematocrit level > 45% 14.1 17.3 .46 9.9 17.1 .06 4.1 4.3 .87
ASA-class 3 64.1 74.3 .05 69.3 78.1 .04 49.6 68.0 .001
ASA-class 4 or 5 30.8 17.1 .002 24.8 11.6 .001 48.5 21.6 .001
*Severe form of occlusive disease that occurs in the lower extremities at rest.
†Absent lower extremity pulses on physical examination.
‡Partially or fully dependent functional status.
SD, Standard deviation; COPD, chronic obstructive pulmonary disease.
To further understand predictors of postoperative
mortality in patients undergoing elective vascular surgery,
we examined the association of race and mortality (Table
IV). Unadjusted mortality was higher (7.2% vs 3.2%; P =
.02) in African Americans compared with whites for AAA
in the 44 VAMCs. Unadjusted morality in LEB and AMP
in the 44 VAMCs and in all three operations in the 79
VAMCs was not statistically significantly different in
African Americans and whites.
To determine the independent association of race and
postoperative mortality, we used multiple logistic regres-
sion to control for preoperative risk factors identified
above (Table III). After controlling for important risk fac-
tors, adjusted 30-day mortality was not statistically signif-
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icantly different between African American and white
patients in the three operations in the 44 VAMCs or the
79 VAMCs (Table V).
DISCUSSION
We examined more than 13,000 vascular operations
performed at 123 VA hospitals and identified several pre-
operative factors that are independently associated with
30-day mortality for patients undergoing AAA, LEB, and
AMP. For these three operations, we found 5, 3, and 10
statistically significant independent predictors of 30-day
postoperative mortality. These predictors were based on
clinical data that were prospectively collected specifically
for the purpose of risk adjustment.
Table III. Multivariable odds ratios for demographic and clinical predictors of 30-day mortality for three operations in
the 44 Department of Veterans Affairs Medical Centers
Operation Risk factor OR 95% CI P value
AAA History of TIA 2.40 1.18, 4.86 .02
Hypertension 2.05 1.18, 3.56 .01
Creatinine level > 1.2 mg/dL 1.97 1.23, 3.16 .005
ASA-class 4 or 5 1.74 1.05, 2.89 .03
History of COPD 1.49 0.92, 2.41 .11
Age 1.02 0.98, 1.06 .31
Albumin level 0.58 0.37, 0.97 .03
LEB Preoperative dialysis 6.21 3.05, 12.67 .0001
ASA-class 4 or 5 2.06 1.29, 3.30 .003
Rest pain* 1.34 0.88, 2.05 .17
Age 1.05 1.03, 1.08 .0001
AMP Venilator dependent 3.17 1.40, 7.16 .006
Dialysis 2.50 1.62, 3.86 .0001
Do-not-resuscitate order 2.24 1.56, 3.23 .0001
Hematocrit level > 45% 2.09 1.06, 4.09 .03
ASA-class 4 or 5 1.93 1.47, 2.55 .0001
Impaired sensorium 1.68 1.23, 2.30 .001
History of COPD 1.53 1.14, 2.06 .004
Creatinine level > 1.2 mg/dL 1.45 1.09, 1.93 .01
Diabetes mellitus 1.40 1.06, 1.86 .02
Absent pulses† 1.39 1.05, 1.83 .0001
Above-knee amputation 1.34 1.01, 1.78 .02
Hypertension 1.27 0.96, 1.68 .04
Age 1.03 1.02, 1.05 .0001
Albumin g/dL 0.59 0.47, 0.74 .09
*Rest pain in the lower extremities.
†Absent lower extremity pulses.
COPD, Chronic obstructive pulmonary disease.
Table IV. Observed 30-day mortality rate by race for each operation and cohort
African American White
Operation Cohort N* % dead N* % dead P value
AAA 44 VAMCs 125 7.2 2143 3.2 .02
79 VAMCs 28 7.1 513 5.3 .67
LEB 44 VAMCs 845 1.7 3724 2.3 .22
79 VAMCs 255 2.4 1276 2.3 .94
AMP 44 VAMCs 1041 7.5 2477 7.8 .79
79 VAMCs 313 5.8 916 7.4 .32
*Total number of patients by race undergoing each operation.
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We found that the 30-day mortality was more than
two times higher in African American patients than in
white patients undergoing AAA. Nonetheless, race was
not an independent predictor of postoperative mortality
after adjusting for other important preoperative risk fac-
tors for AAA, LEB, or AMP.
Earlier studies examined death after vascular surgery in
patients on Medicare20 and in elderly patients in the
Netherlands.21 Most earlier studies of vascular surgery mor-
tality rate are reports from a single site or were made on the
basis of hospital claims databases that do not contain
detailed clinical information about patients’ medical history
and physical and laboratory examinations.15,22-34 Our find-
ings for 30-day postoperative mortality for AAA of 3.2%,
LEB of 2.3%, and AMP of 7.8% are consistent with mortal-
ity rates found in earlier studies of vascular surgery. The
range of mortality rates found in the literature is 2% to 6%
for AAA,22-24 2.3% to 8% for LEB,15,27-29 and 0.9% to 20%
for AMP.30-34 Some studies15,30-34 have not excluded emer-
gency vascular surgery, and, as might be expected, substan-
tially higher postoperative mortality rates were found.
These studies are not directly comparable with the current
study of elective vascular surgery.
We used data collected by the VA NSQIP.5-8 The
NSQIP developed risk-adjusted models for nine surgical
subspecialties, including vascular surgery, to predict 30-
day mortality. Models from the NSQIP were not pro-
duced for specific vascular operations. The models that
were developed earlier for vascular disease were a means of
identifying several risk factors for postoperative death. For
this study, we separated specific elective vascular opera-
tions and identified similar risk factors for postoperative
death. Notably, age, albumin level, ASA class, and an ele-
vated creatinine level were important risk factors in
surgery-specific models developed for the current study
and in a broader definition of operations performed in the
subspecialty of vascular surgery.
Few studies have assessed mortality rate differences by
race for patients undergoing elective surgery. In one study
that specifically assessed mortality rate by race for patients
who underwent surgery for peripheral vascular disease,15
there was no statistically significant difference in operative
mortality rates.
Our findings may be influenced by several factors par-
ticular to the relationship of mortality after elective vascu-
lar surgery and race. First, we could not examine the rela-
tionship of mortality or other outcomes to surgery-specific
variables such as aneurysm size because these data are
unavailable. Second, our comparisons by race may have
been limited by the smaller number of African American
patients who underwent surgery (ie, AAA) or differences
by race in use of elective versus emergency surgery. Third,
our study sample was limited to elderly male veterans and
may not generalize to other populations. Finally, the indi-
cations for AMP were not defined within the NSQIP data-
base. However, absent lower extremity pulses was a
statistically significant independent risk factor for 30-day
mortality rate among those patients who underwent an
elective AMP. This risk factor is more likely associated with
peripheral arterial disease.
Our results are based on data from the VA NSQIP, a
successor to the National VA Surgical Risk Study, the
largest prospective observational study to date on surgical
morbidity and mortality. These results build on and
extend the results of earlier work by developing risk
adjustment models specific for AAA, LEB, and AMP and
by using these models as a means of exploring the associ-
ation of race with morbidity and mortality rates of patients
undergoing vascular surgery.
This study has identified important independent pre-
dictors of 30-day postoperative mortality rate for three
surgical operations. At a time when comparisons of out-
comes are becoming increasingly important, this study
highlights the importance of risk-adjusting outcomes with
data collected specifically for this purpose.
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